| Report ID | 277232 |
| Drug Identification Number | 02526778 |
| Brand name | CAFFEINE CITRATE INJECTION USP |
| Common or Proper name | CAFFEINE CITRATE INJECTION USP |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CAFFEINE CITRATE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 x 3 mL vial / fiole |
| ATC code | N06BC |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-02-20 |
| Estimated end date | 2026-03-13 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-10 | French | Compare |
| v3 | 2026-02-10 | English | Compare |
| v2 | 2026-02-04 | French | Compare |
| v1 | 2026-02-04 | English | Compare |
Showing 1 to 4 of 4